survodutide

Boehringer kickstarts two Phase III trials as MASH therapy wins breakthrough status
Clinical Trials Arena
Tue, 10/8/24 - 09:56 am
Boehringer Ingelheim
MASH
clinical trials
survodutide
Boehringer, Lilly face off in MASH at EASL
Pharmaphorum
Mon, 06/10/24 - 11:14 am
Eli Lilly
Boehringer Ingelheim
MASH
EASL
tirzepatide
survodutide
Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data
BioSpace
Fri, 06/7/24 - 11:17 am
Boehinger Ingelheim
Zealand Pharma
survodutide
MASH
NASH
Boehringer, Zealand’s GLP-1 MASH Data ‘Unintentionally’ Published by Medical Congress Website
BioSpace
Thu, 06/6/24 - 11:48 am
Zealand Pharma
Boehringer Ingelheim
MASH
survodutide
clinical trials
Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up
BioSpace
Mon, 05/6/24 - 11:33 am
Boehringer Ingelheim
Walgreens
obesity
type 2 diabetes
clinical trials
survodutide
Boehringer’s survodutide shows monster MASH potential
Pharmaphorum
Mon, 02/26/24 - 10:36 am
Boehringer Ingelheim
weight loss
MASH
NASH
survodutide
Boehringer moves obesity therapy into phase 3
Pharmaphorum
Fri, 10/6/23 - 10:01 am
Boehringer Ingelheim
Zealand Pharma
clinical trials
obesity
survodutide
Boehringer preps phase 3 for dual-action obesity drug
Pharmaphorum
Thu, 08/17/23 - 09:54 am
Boehringer Ingelheim
clinical trials
obesity
survodutide
Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect
Fierce Biotech
Sun, 06/25/23 - 09:46 pm
Boehringer Ingelheim
obesity
clinical trials
Zealand Pharma
survodutide